Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07277673

Aerobic Exercise Addition to Cognitive Behavioural Treatment in Impotence Metabolic-syndrome Drinkers

Is There a Benefit of Aerobic Exercise Addition to Cognitive Behavioural Treatment in Heavy Drinking Men With Impotence and Metabolic Syndrome?

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
Male
Age
35 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Cognitive Behavioural Treatment is used as treatment for Heavy Drinking, Impotence, and Metabolic Syndrome. The efficacy of adding aerobic training to this treatment is not tested till now.

Detailed description

Forty men with Heavy Drinking, Impotence, and Metabolic Syndrome will be included. catogorization will be performed to assign them to group number I or group number II. Every group will involve/contain twenty males. Both groups will receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks). Also, Group number I will also adminsiter supervised aerobic training (walking on electrical treamill, 50 minute per the session , three times/week, for 12 weeks).

Conditions

Interventions

TypeNameDescription
BEHAVIORALaerobci physical training and cognitive behavioural treatmentTwenty men with Heavy Drinking, Impotence, and Metabolic Syndrome receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks). Also, men will also adminsiter supervised aerobic training (walking on electrical treamill, 50 minute per the session, three times/week, for 12 weeks).
BEHAVIORALCognitive behavioural treatmentTwenty men with Heavy Drinking, Impotence, and Metabolic Syndrome will receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks)

Timeline

Start date
2025-10-10
Primary completion
2026-02-15
Completion
2026-02-15
First posted
2025-12-11
Last updated
2025-12-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07277673. Inclusion in this directory is not an endorsement.